A 52-year-old man with major depressive disorder is prescribed sertraline (SSRI). His wife asks why he was not given amitriptyline (TCA), which worked for her depression years ago. Which clinical feature most strongly justifies the preference for sertraline over amitriptyline in this patient?

Explanation

## Safety and Drug Interaction Profile: SSRI Advantage ### Why SSRIs Are First-Line **Key Point:** SSRIs are preferred over TCAs as first-line antidepressants primarily because of: 1. **Wide therapeutic window** — safe in overdose (rarely fatal) 2. **Minimal drug–drug interactions** — no blockade of cardiac sodium channels or anticholinergic receptors 3. **Better tolerability** — fewer anticholinergic and cardiovascular side effects ### Safety Comparison | Aspect | SSRI (Sertraline) | TCA (Amitriptyline) | | --- | --- | --- | | Lethal dose | Very high (>10 g) | Low (1–5 g) | | Cardiac toxicity | Minimal | Significant (QT↑, arrhythmias) | | Anticholinergic effects | Minimal | Prominent (dry mouth, retention) | | Drug interactions | Few (mild CYP450) | Many (protein binding, metabolism) | | Elderly tolerance | Excellent | Poor | | Overdose management | Supportive care | ICU monitoring, antiarrhythmics | ### Clinical Pearl **High-Yield:** In a general adult population without contraindications, SSRIs are universally recommended as first-line because they combine efficacy with safety. TCAs are reserved for: - Patients with comorbid pain syndromes (neuropathic pain, fibromyalgia) - Treatment-resistant depression (after SSRI/SNRI failure) - Patients requiring sedation (amitriptyline, doxepin) ### Mnemonic **SSRI Safety:** **S**afe in **S**uicide (overdose), **S**afe in **S**eniors, **S**afe in **S**ystemic disease [cite:Harrison 21e Ch 470]